Hodgkin lymphoma in the elderly, pregnant, and HIV-infected

Area of Science:

• Oncology
• Hematology

Background:

• Hodgkin lymphoma (HL) presents unique management challenges in patients with advanced age, pregnancy, or HIV.
• Existing treatment guidelines may not adequately address these specific patient populations.

Purpose of the Study:

• To provide evidence-based recommendations for the diagnosis and therapeutic management of HL in patients with advanced age, pregnancy, or HIV.
• To integrate recent clinical evidence and expertise for these challenging HL cases.

Main Methods:

• Review of recent scientific literature on HL management in specific patient groups.
• Integration of clinical expertise to formulate diagnostic and therapeutic strategies.
• Focus on individualized treatment approaches based on patient comorbidities and disease presentation.

Main Results:

• For older patients, careful comorbidity evaluation and judicious chemotherapy selection are crucial to minimize functional compromise.
• For pregnant patients, staging should minimize ionizing radiation, and treatment may involve deferral, single-agent vinblastine, or multi-agent chemotherapy for aggressive disease.
• For patients with HIV, treatment combines highly active anti-retroviral therapy (HAART), standard chemotherapy with attention to drug interactions, and supportive care.

Conclusions:

• Tailored diagnostic and therapeutic strategies are essential for managing HL in older adults, pregnant individuals, and those with HIV.
• Individualized treatment plans optimizing chemotherapy, supportive care, and consideration of specific patient factors are key to improving outcomes.
• Further research may be warranted to refine management protocols for these complex HL presentations.